<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">

SmartTRAK Life Sciences News and Analysis Blog

10 min read

MedTech Innovation in the Time of COVID

By Thomas Wallick on 8/11/20 8:00 AM

Despite the unprecedented challenges of the ongoing pandemic, and the collateral economic hit taken due to the massive decline in elective procedures in Q220, MedTech companies continue to innovate and introduce new products to the global life sciences industry.

The following is just a small sampling of the new products updates from around the world compiled, reviewed and posted in real time last week by our SmartTRAK analysts. We constantly monitor the worldwide MedTech industry, sifting through the noise to present to our subscribers the most relevant international news, trends, new products, financial data and competitor developments in the global Life Sciences industry.

In Q220, Alphatec commenced upgrades of its cervical portfolio with 510(k) clearance of the Insignia Anterior Cervical Plate System and InVictus CT Spinal Fixation System, which expands InVictus across cervical, thoracic and lumbar procedures.

GMED has launched 6 new products in 2020 w/ strong uptake of HEDRON 3D printed IBD spacers as well as SABLE expandable MIS TLIF device. Globus is doubling its 3D manufacturing capacity which should come online in Q4. GMED Q220 Earnings Transcript on Seeking Alpha

Alpha launches for COHERE TLIF O and TLIF A are slated for 2020, expanding the Company’s proprietary porous PEEK platform. NUVA Q220 Earnings Transcript on Seeking Alpha

Topics: COVID-19
Continue Reading
2 min read

Spine Market COVID-19 Update: Quick Rebound?

By Julianne Burns on 8/6/20 9:30 AM

The latest intel suggests the spine market is rebounding more quickly than expected, but certain new market dynamics will persist.

While much remains up in the air, early data suggests the spine market is rebounding more quickly than expected. Surgeons are beginning to perform cases that were postponed through March and April due to COVID-19. In conversations with WFS analysts,  NuVasive* (NUVA) management reported a mix of both deferred cases and new volume in May. NUVA’s spine business reportedly tracked ~50% below pre-COVID levels in May versus ~70% below in April. The Company’s current trajectory and consensus expectations for the quarter implies a recovery in procedure volumes to 35% below pre-COVID levels in June according to  WFS NUVA: Takeaways From The 2020 “Virtual” Bus Tour Report. Similarly, Canaccord Genuity estimates  Alphatec’s* FY20 US revenue will be down –9.7% YoY with an estimated -45.6% drop in Q220 sales. This assumes the impact from COVID-19 started in mid-March, April revenues were down ~60-70%, and notable improvement began in early May as more states resume procedures.
Topics: Orthopedics
Continue Reading
8 min read

International MedTech News Updates: The Week in Review

By Thomas Wallick on 8/4/20 8:40 AM

The unprecedented challenges from the current resurgence of COVID-19 cases worldwide continues to concern the MedTech industry as it strives to develop ways to deal with a post-pandemic world. Despite the struggling global economy, demand for innovative medical devices and advanced technologies will continue to drive long term growth.
 
The following is just a small sampling of the updates from around the world compiled, reviewed and posted in real time last week by our SmartTRAK analysts. We constantly monitor the worldwide MedTech industry, sifting through the noise to present to our subscribers the most relevant international news, trends, financial data and competitor developments in the global Life Sciences industry.
 
June in Russia

In the pharmacies in Russia, commercial drug June sales increased by 0.1% in value vs May 2020. Compared to June 2019, sales increased by 2.1%. The increase in the first 6 mos in 2020 was 13.9% vs the same period in 2019.

Teleconsultation in France

During the lockdown in April, 27% of all consultations were teleconsultations in France. Of doctors carrying out teleconsultations, 50% were under 50 yrs old, though that age group represents only 37% of all GPs.

MedTech World in Germany

MedTech companies in Germany expect sales to decline an avg of 8% in 2020 due to the pandemic, including 12% in int’l business according to a survey. Almost 60% of companies expect a double-digit drop.

Continue Reading
3 min read

Stroke Care During an Evolving Pandemic: An Interview with J Mocco, MD

By Anne Staylor on 7/30/20 11:29 AM

J Mocco, MD, MS discusses how an evolving pandemic is affecting stroke care in an interview with SmartTRAK

The COVID-19 pandemic has dramatically disrupted health care around the world and is wreaking havoc on medical device markets. In the US, social distancing and other mitigation efforts have helped flatten the curve and many states are now working toward reopening their economies.

The pandemic continues to evolve and its impact on healthcare delivery systems is rapidly changing. Elective surgery has re-started again in many states and hard-hit places like New York City have seen COVID-19 cases peak and start to trend downward. So how are these trends affecting stroke care? Why are strokes up in some regions but down in others? When will neurointerventional procedure volumes return to pre-COVID levels? To find out the answers to these questions and more, SmartTRAK talked with J Mocco, MD, MS, Vice Chair, Department of Neurosurgery and Professor of Neurosurgery at Mount Sinai Health System in New York City.

To listen to the interview recorded via Uberconference on Monday May 11, click on the following video. A transcript of the interview can be downloaded here.

Continue Reading
5 min read

SAWC Spring 2020 Goes Virtual: The Week In Wound Care

By Thomas Wallick on 7/28/20 7:53 AM

As the COVID-19 continues to affect every aspect of life, the MedTech industry perseveres in its attempt to adapt and continue moving forward. SAWC and the Wound Healing Society held the SAWC Spring 2020 as a virtual experience on July 24-26. In their words "At a time when so much else is canceled, the work to treat, manage, and prevent chronic wounds and improve patient care cannot stop. Hope must go on."

The following is a small sampling of the updates compiled, reviewed and posted in real time last week by our SmartTRAK analysts, including many from SAWC 2020. We constantly monitor the worldwide MedTech industry, sifting through the noise to present to our subscribers the most relevant international news, trends, financial data and competitor developments in the global Life Sciences industry.

COVID-19 and Chronic Wound Patients

Dr. Margaret A Liu, an expert in vaccines and immunotherapies, provided an excellent presentation on the intersection of vaccine technologies for COVID-19, disease pathology for pts w/ chronic wounds, and how it fits together with a global pandemic. SAWC 2020 Virtual

Topics: Wound Care
Continue Reading
3 min read

SmartTRAK Analysts Featured in Cartilage.org ICRS Newsletter

By Thomas Wallick on 7/24/20 1:18 PM

SmartTRAK, the leading source of competitive intelligence used by the top global orthopedic & wound care companies, had four articles featured in the International Cartilage Regeneration & Joint Preservation Society Summer 2020 Issue. These articles were originally published on the SmartTRAK platform.

The ICRS is the main forum for international collaboration in cartilaginous tissue research and joint preservation whose stated mission is "Advancing Science & Education of the Prevention & Treatment of Cartilage Disease Worldwide."

Kim French, SmartTRAK's Senior Analyst, OrthoBio, had three of her articles included in the Summer 2020 issue:

Continue Reading
6 min read

Double Whammy Impacts Strong Start: Q120 Computer Assisted Surgery Spine Mkt

By Elise Wolf on 7/22/20 9:31 AM

Strong start in Q120 was negatively impacted by the double whammy of postponed elective procedures and lag in capital equipment purchases as the result of the COVID-19 pandemic.

While adoption of robotics and other enabling technologies was gaining significant momentum quarter over quarter through year-end 2019, delays in elective spine surgery due to the COVID-19 pandemic resulted in declines in capital equipment sales and fewer computer-assisted spine surgeries in Q120. However, these declines are expected to be temporary and improve as surgeries rebound through the end of the year and into 2021.

Among the many topics covered in the comprehensive Q120 CAS Spine Market Recap* are:

Topics: Orthopedics
Continue Reading
8 min read

Recovery Predictions, Elective Surgery and Future Outbreaks: COVID-19 Updates

By Thomas Wallick on 7/20/20 1:40 PM

As the COVID-19 pandemic progresses and continues to affect everyday life around the world, the path that lies ahead for the MedTech industry and the search for effective therapeutics and vaccines remains hard to predict.

The following is a small sampling of the updates compiled, reviewed and posted in real time last week by our SmartTRAK analysts. We constantly monitor  the worldwide MedTech industry, sifting through the noise to present to our subscribers the most relevant international news, trends, financial data and competitor developments in the global Life Sciences industry.

SVBLeerink Expects Q2 Recovery to Exceed Expectations 
Based on prelim Q220 MedTech Company results, SVB Leerink expects May/June COVID recovery to exceed expectations noting elective procedure shutdowns are regionalized and halts are not expected to be as bad or prolonged as in March/April. SVBLeerink Medical Supplies and Devices
 
Positive COVID-19 Vaccine Data Could Fuel Medtech Sectors

With 4 of the leading vaccine candidates expected to enter Phase 3 studies in July (Sinovac, Moderna, BioNTech/PFE, CanSino), Phase 2 data could be reported in summer/fall 2020. If +, WFS says it could be a catalyst for some medtech sectors in recovery of elective procedures.

Public Perception of Resuming Elective Surgery

A survey assessing public perceptions towards resuming elective surg found out of 722 people 61% were concerned w/ contracting COVID-19 during surg. Overall, 57% would have surgery at a hospital vs outpatient and 27% would undergo surg in the first mo of reopening. J Arthroplasty

Preparation for Future Outbreaks

The European Commission published a document about the preparedness of health systems in Europe for future COVID-19 outbreaks. Topics comprise testing, contact tracing, surveillance, accessibility of medical devices and capacity measures.

Continue Reading
6 min read

Q120 Computer Assisted Surgery Ortho Revenue Hit with 1-2 Punch

By Elise Wolf on 7/16/20 10:12 AM

 

Companies came out of the gate strong in Q120, but COVID-19’s one-two punch on elective procedures and capital equipment purchases negatively impacted orthopedic enabling technology revenues toward the end of the quarter.

While adoption of robotics and other enabling technologies was gaining significant momentum quarter over quarter through year-end 2019, delays in elective spine surgery due to the COVID-19 pandemic resulted in declines in capital equipment sales and fewer computer-assisted orthopedic surgeries in Q120.

Among the many topics covered in the comprehensive Q120 CAS Ortho Market Recap* are:

Continue Reading
9 min read

Novel Ideas, New Products and Innovative Studies: The Week in OrthoBio

By Thomas Wallick on 7/14/20 8:00 AM

The orthobiologics market continues to ramp up studies and new product development as surgeries impacted by COVID-19 are rescheduled. The following is a small sampling of the OrthoBio updates compiled, reviewed and posted in real time last week by our SmartTRAK analysts. We constantly monitor  the worldwide MedTech industry, sifting through the noise to present to our subscribers the most relevant international news, trends, financial data and competitor developments in the global Life Sciences industry.

KAPPA Opiod - Possible DMOAD? 

KECK Medicine of USC has published a preclinical study demonstrating the potential of a new opioid medication that may slow OA progression while being less addictive. The therapy MOA is kappa opioid receptor (KOR) modulation via inhibition of hedgehog signaling. Arthritis Rheum

Association of SNPs in MMPs Genes and Knee OA

A 200-pt prospective, case-control study is underway to assess if the presence of gene polymorphisms (1575 G/A MMP-2, 836 A/G MMP-9 and -77 A/G MMP-13) in the metalloproteinases (MMPs) affect the risk of developing idiopathic kOA in the Greek population. clinicaltrials.gov

National Rates and Risk Factors of Failed Primary RCR

An insurance database review w/ 41,467 primary RCR pts (41,844 shoulders) showed 52.7% male, 60-69 yrs of age most prevalent (~38%) and 8.38% revision rate. Revision risk factors were increasing age, male sex, smoking, obesity, hyperlipidemia and vitamin D deficiency. Arthroscopy

Continue Reading

    Recent Articles